Prioritization of neurodevelopmental disease genes by discovery of new mutations.

Abstract excerpt

Advances in genome sequencing technologies have begun to revolutionize neurogenetics, allowing the full spectrum of genetic variation to be better understood in relation to disease. Exome sequencing of hundreds to thousands of samples from patients with autism spectrum disorder, intellectual disability, epilepsy and schizophrenia provides strong evidence of the importance of de novo and gene-disruptive events....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exome
• Share to Genetic Association Studies
• Share to Genetic Predisposition to Disease